Colitis, Ulcerative

"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.

Descriptor ID	D003093
MeSH Number(s)	C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
Concept/Terms	Colitis, Ulcerative Colitis, Ulcerative Idiopathic Proctocolitis Ulcerative Colitis Colitis Gravis Inflammatory Bowel Disease, Ulcerative Colitis Type

Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".

Diseases [C]
Digestive System Diseases [C06]
Gastrointestinal Diseases [C06.405]
Gastroenteritis [C06.405.205]
Colitis [C06.405.205.265]
Colitis, Ulcerative [C06.405.205.265.231]
Inflammatory Bowel Diseases [C06.405.205.731]
Colitis, Ulcerative [C06.405.205.731.249]
Intestinal Diseases [C06.405.469]
Colonic Diseases [C06.405.469.158]
Colitis [C06.405.469.158.188]
Colitis, Ulcerative [C06.405.469.158.188.231]
Inflammatory Bowel Diseases [C06.405.469.432]
Colitis, Ulcerative [C06.405.469.432.249]

Below are MeSH descriptors whose meaning is related to "Colitis, Ulcerative".

Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.

Bar chart showing 41 publications over 20 distinct years, with a maximum of 4 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	2	2
2000	1	1	2
2001	1	0	1
2002	1	1	2
2003	0	1	1
2006	3	0	3
2007	1	0	1
2008	1	0	1
2009	2	0	2
2011	1	0	1
2012	1	0	1
2015	2	0	2
2018	3	0	3
2019	1	0	1
2020	3	0	3
2021	2	1	3
2022	3	0	3
2023	3	0	3
2024	3	1	4
2025	1	1	2

Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.

Chen S, Putnik R, Li X, Diwaker A, Vasconcelos M, Liu S, Gondi S, Zhou J, Guo L, Xu L, Temme S, Bersch K, Hyland S, Yin J, Burstein E, Bahnson BJ, Gildersleeve JC, Grimes CL, Reinecker HC. PGLYRP1-mediated intracellular peptidoglycan detection promotes intestinal?mucosal protection. Nat Commun. 2025 Feb 21; 16(1):1864.

View in: PubMed
Desai A, Sehgal P, Khataniar H, Lewis JD, Farraye FA, Lichtenstein GR, Kochhar GS. Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S. Aliment Pharmacol Ther. 2025 Apr; 61(7):1197-1207.

View in: PubMed
Ghodasara SK, Hauser KM, Oldewurtel KM, Rolandelli RH, Nemeth ZH. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease. Am Surg. 2024 Nov; 90(11):2921-2929.

View in: PubMed
Sehgal P, Su S, Zech J, Nobel Y, Luk L, Economou I, Shen B, Lewis JD, Freedberg DE. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not. Inflamm Bowel Dis. 2024 04 03; 30(4):594-601.

View in: PubMed
Godoy-Brewer G, Salem G, Limketkai B, Selaru FM, Grossen A, Policarpo T, Haq Z, Parian AM. Use of Biologics for the Treatment of Inflammatory Conditions of the Pouch: A Systematic Review. J Clin Gastroenterol. 2024 02 01; 58(2):183-194.

View in: PubMed
Ghodasara SK, Roskam JS, Uretsky M, Chang GC, Rolandelli RH, Nemeth ZH. Effects of the COVID-19 Pandemic on Colectomy Outcomes for Inflammatory Bowel Disease. South Med J. 2024 02; 117(2):88-92.

View in: PubMed
Van NT, Zhang K, Wigmore RM, Kennedy AI, DaSilva CR, Huang J, Ambelil M, Villagomez JH, O'Connor GJ, Longman RS, Cao M, Snook AE, Platten M, Kasenty G, Sigal LJ, Prendergast GC, Kim SV. Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nat Commun. 2023 11 14; 14(1):7363.

View in: PubMed
Thomas S, Dilbarov N, Kelly J, Mercogliano G, Prendergast GC. Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis. Sci Rep. 2023 07 21; 13(1):11802.

View in: PubMed
Hill SS, Ottaviano KE, Palange DC, Chismark AD, Valerian BT, Canete JJ, Lee EC. Impact of Preoperative Factors in Patients With IBD on Postoperative Length of Stay: A National Surgical Quality Improvement Program-Inflammatory Bowel Disease Collaborative Analysis. Dis Colon Rectum. 2024 01 01; 67(1):97-106.

View in: PubMed
Thomas S, Mercogliano G, Prendergast GC. Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment. PLoS One. 2022; 17(11):e0276910.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement